SC Filed 2018-07-09 Event — SEC 0001140361-18-031924 →

Novartis Bioventures Ltd → Aerpio Pharmaceuticals, Inc. WHWK

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 1 sales · 0 awards/exercises

Issuer Cluster

9 13D/G filings on this issuer

8 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 3.88

693,909 shares short · -3.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-13	BALL BRYAN	officer	Sale	26,389	$3.46	$91K

Other 13D/G Filings on Aerpio Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2025-03-06	SCHEDULE	Desai Neil	4.90%	2,272,941	view →
2025-03-04	SCHEDULE	Avoro Capital Advisors LLC	19.99%	11,914,961	view →
2025-02-24	SCHEDULE	BML Investment Partners, L.P.	9.90%	2,435,000	view →
2025-02-04	SCHEDULE	BML Investment Partners, L.P.	9.90%	2,435,000	view →
2025-01-24	SCHEDULE	ACUTA CAPITAL PARTNERS, LLC	7.80%	1,921,297	view →
2024-10-01	SC	Desai Neil	—	—	view →
2018-07-03	SC	Satter Muneer A	—	—	view →
2018-07-02	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Novartis Bioventures Ltd

Filed	Form	Issuer	Stake	Shares
2018-04-17	SC	Novus Therapeutics, Inc. ELDN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →